Safety and potential efficacy of DM199, a tissue kallikrein-1 analogue, for treating pre-eclampsia and fetal growth restriction: study protocol for a South African, hospital-based phase I/II open-label trial.
Authors: Cluver CA, Thake J, Hassim T, van Greunen A, Budhram S, Knipe K, Decloedt E, Brink L, Langenegger E, Bergman L, Imberg H, Bekker A, Walker SP, Tong S. DOI: 10.1136/bmjopen-2025-104035 Abstract Summary...
Read moreDetails




